Trial site
Hospital Universitario Insular de Gran Canaria
- 7running trials
- 8closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Melanoma3 trials
- Bladder cancer2 trials
- Head and neck cancer2 trials
- Myeloproliferative neoplasms2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Diabetic eye disease1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Graves' disease1 trial
- Kidney cancer1 trial
- and 6 more
- Phase
- Phase 35 trials
- Phase 23 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Completed4 trials
- Recruiting4 trials
- Terminated4 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Fundación GECP2 trials
- Incyte Corporation2 trials
- BicycleTx Limited1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Grupo Espanol de Tumores Neuroendocrinos1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
Active, not recruiting
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Recruiting
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Melanoma3 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Terminated
Terminated
Completed
First Line Atezolizumab, Paclitaxel, and Bevacizumab (Avastin®) in mTNBC
Terminated
Completed
Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease.
Site data: ClinicalTrials.govUpdated 13 Nov 2026